VRTX Vertex Pharmaceuticals Inc

0.95 (0.27%)
Last Updated: 11:59:39
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Vertex Pharmaceuticals Financial Summary

The current VRTX market cap is 90.75B. The company's latest EPS is 12.87 and P/E is 27.18.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.05B4.16B6.21B7.58B8.99B
Operating Income 635.15M1.2B2.86B2.78B4.31B
Net Income 2.1B1.18B2.71B2.34B3.32B
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 6.25B8.32B11.75B13.43B18.15B
Total Liabilities 1.81B2.23B3.06B3.33B4.24B
Total Equity 4.44B6.09B8.69B10.1B13.91B
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 1.27B1.57B3.25B2.64B4.13B
Investing -202.16M-1.24B99.39M-340.9M-321.1M
Financing -71.22M126.77M-505.28M-1.48B-67.7M
Market Cap 90.75B
Price to Earnings Ratio 27.18
Price to Sales Ratio 10.04
Price to Cash Ratio 8.59
Price to Book Ratio 6.49
Dividend Yield -

Share Statistics

Shares Outstanding 258.09M
Average Volume (1 week) 880.29k
Average Volume (1 Month) 926.89k
52 Week Change 24.38%
52 Week High 366.9999
52 Week Low 276.57
Spread (Intraday) 0.25 (0.07%)

Company Info

Company Name Vertex Pharmaceuticals Inc
Address 50 northern avenue
boston, massachusetts 02210
Website https://www.vrtx.com
Industry pharmaceutical preparations (2834)